Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Changes in CD4 + T cells subsets in patients with alcohol-related cirrhosis

  • Zuluaga Blanco, Yenny Paola|||0000-0002-0247-0351
  • Zurera Egea, Coral|||0000-0003-1712-5216
  • Fuster, Daniel|||0000-0003-1262-5860
  • Hernandez Rubio, Anna|||0000-0001-8612-7827
  • Teniente Serra, Aina|||0000-0003-3440-804X
  • Martínez Cáceres, Eva María|||0000-0002-6762-8025
  • Muga, Roberto|||0000-0001-6301-431X
Alcohol-related cirrhosis (AC) is a condition that impacts in immunity. We analyzed changes over time in CD4 + subsets in AC-patients. We included patients with alcohol use disorder admitted at least twice for treatment. Patients without evidence of liver disease were the control group (CG). We analyzed naïve, memory, TEMRA, Th1, Th2, Th17, early activated, and late activated subsets. During the follow-up, TEMRA T cells were increased (1.2 ± 1.1% vs. 2.1 ± 1.1%, p = 0.03) in AC-patients (n = 5) and Th17 cells were decreased (14.1 ± 4.3% vs. 12.3 ± 6.4%, p = 0.03) in the CG (n = 22). Late activated cells were associated with a decrease in memory cells in both the groups. This association was stronger in AC-patients (r = - 0.90, p = 0.04). The proportion of memory cells was correlated with an increased of Th1/Th2/Th17 cells in the CG (r = 0.70, r = 0.68, r = 0.63; p < 0.01, respectively), whereas in AC-patients was correlated with a decrease in Th17 cells (r = - 0.90, p = 0.03). AC-patients showed an increase in the proportion of TEMRA T cells, loss of heterogeneity and decreased CD4 + differentiation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans

  • Caicedo di Filippo, Dolly Andrea|||0009-0009-6523-0265
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Papaseit, Esther|||0000-0003-2620-4274
Cannabis is the most commonly used illicit substance worldwide. Recent years have seen an increase in cannabis consumption, and with new approvals and therapeutic indications, there are challenges in minimizing the risks and interactions between cannabis-based products, cannabis prescription drugs, other approved prescription drugs, and other substances of abuse. Thus, identifying the enzymes metabolizing cannabinoid drugs and their relationship with other prescription drugs is crucial for understanding the potential interactions and effects of their simultaneous use. This article offers a comprehensive review of cannabis and the pharmacokinetic interactions between cannabis products, cannabis prescription drugs, and other approved prescription drugs, as well as other substances of abuse. It also compiles existing evidence of these interactions and describes the clinical outcomes associated with the inhibition or induction of various enzymes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder

  • Zuluaga Blanco, Yenny Paola|||0000-0002-0247-0351
  • Casado-Carbajo, Julia
  • Hernandez Rubio, Anna|||0000-0001-8612-7827
  • Bueno-Vélez, Marvin
  • García-Martin, Carmen
  • Muga, Roberto|||0000-0001-6301-431X
  • Fuster, Daniel|||0000-0003-1262-5860
Background: Vitamin D deficiency is a risk factor for liver disease, insulin resistance, and beta cell dysfunction. Individuals with alcohol use disorder (AUD) have many comorbidities, with a heavy burden of liver disease and metabolic complications, including type 2 diabetes mellitus (T2DM). Objective: We aimed to analyze the prevalence and associations of vitamin D deficiency in patients admitted for in-hospital treatment of AUD. Methods: A cross-sectional study was conducted in patients consecutively admitted for the treatment of AUD between January 2017 and October 2023. Sociodemographic data, substance use characteristics, and blood parameters were available at admission. Vitamin D status was assessed through the serum concentrations of 25-hydroxyvitamin D [25(OH)D] levels using a direct competitive chemiluminescent immunoassay method. Deficiency of vitamin D was defined as a concentration less than 20 ng/mL; impaired fasting glucose (IFG) was defined by fasting blood glucose.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Is There an Association Between Cigarette Smoking and Advanced Liver Fibrosis in Smokers with HIV, Heavy Drinking and High Prevalence of HCV?

  • Fuster, Daniel|||0000-0003-1262-5860
  • So-Armah, Kaku|||0000-0003-1505-6384
  • Cheng, Debbie M.
  • Blokhina, Elena
  • Patts, Gregory
  • Lioznov, Dmitry|||0000-0003-3643-7354
  • Gnatienko, Natalia
  • Long, Michelle T.
  • Freiberg, Matthew S.|||0000-0002-3699-4022
  • Tindle, Hilary|||0000-0002-7581-7483
  • Samet, Jeffrey H.|||0000-0002-0897-3400
Background: Cigarette smoking has been associated with liver fibrosis in the setting of hepatitis C virus (HCV) infection but has not been studied among people with HIV (PWH) who consume alcohol. Methods: This is a cross-sectional study of PWH with heavy drinking and daily smoking in St. Petersburg, Russia. The primary independent variable was past 30-day cigarettes per day (cpd), and the secondary independent variable was pack-years at study entry. Advanced liver fibrosis was defined as FIB-4 > 3.25. Analyses were adjusted for gender, body mass index (BMI), past 30-day number of heavy drinking days, HCV and CD4 count. Results: Participants (n = 400) were two-thirds male (67.3%), young (median age 38 years), lean (median BMI 22), HCV antibody positive (84.5%) and not severely immune suppressed (median CD4 count 351). The median number of past-month cpd was 20 (IQR: 15-25), and the median pack-years was 24 (IQR: 17-31.8). The prevalence of advanced liver fibrosis was 11.3% (45/400). In the adjusted logistic regression analyses, we did not observe a significant association between cpd [middle (10.1-20 cigarettes) vs. lowest (5-10 cigarettes) category (adjusted odds ratio [aOR] (95% confidence interval [CI]): 1.06 (0.40-2.83), highest (>20.0 cigarettes) vs. lowest category aOR (95% CI): 0.65 (0.21-1.99), global p -value = 0.62]. The secondary analysis with pack-years yielded similar results [middle (20.1-30 pack-years) vs. lowest category (≤20 pack-years) aOR (95% CI): 0.81 (0.33-1.99), highest category (>30 pack-years) vs. lowest category aOR (95% CI): 0.91 (0.38-2.19); global p -value = 0.58]. Conclusions: In this Russian cohort of PWH, we did not detect an association between recent cigarette use or mean pack-years and advanced liver fibrosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

No significant gender differences in driving-related skills following alcohol mixed with energy drinks during an experimental binge-drinking episode

  • Hladun, Olga|||0000-0002-6230-5876
  • Papaseit, Esther|||0000-0003-2620-4274
  • Poyatos, Lourdes|||0000-0002-4641-8600
  • Martín, Soraya|||0009-0008-3761-9217
  • Pérez-Acevedo, Ana Pilar|||0000-0001-5647-4529
  • Barriocanal, Ana María|||0000-0002-4159-519X
  • Bustos Cardona, Tatiana
  • Malumbres, Susana
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Langohr, Klaus|||0000-0001-7075-9192
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
Consumption of alcohol mixed with energy drinks (AmEDs) is trendy among young people. It has been related to risk-taking behaviors like binge drinking and driving under the influence of alcohol. Previous data suggest that women are more sensitive to alcohol-induced impairment. The aim of the study was to assess whether women experience greater acute effects (on driving-related skills and subjective and physiological responses) after the controlled administration of alcohol and energy drinks in an experimental binge-drinking episode. A randomized, crossover, double-blind clinical trial was conducted with 28 healthy volunteers (14 men and 14 women) across four treatment conditions, namely, alcohol + energy drink (A/ED), alcohol + placebo of ED (A), placebo of alcohol + ED (ED), and both placebos (P). Men received 70 g of alcohol and women received 55 g, combined with 750 mL and 589 mL of ED, respectively; these were administered over 80 min, mimicking a binge-drinking episode. Driving-related skills (measured by a tracking test and the psychomotor vigilance task), subjective effects (using the visual analog scales (VASs, Biphasic Alcohol Effects Scale (BAES), and Addiction Research Center Inventory (ARCI)), vital signs, and alcohol and caffeine concentrations were measured over an 8-h period. Peak alcohol concentrations in breath air were 0.46 mg/L in both genders, despite the alcohol dose being 21% lower in women. Similar peak blood caffeine concentrations were observed in men and women (4,500 ng/mL vs. 4,635 ng/mL with A/ED, higher than those with ED). Women reported greater drunkenness (effect size: 45 mm; 95% CI: 5-85 mm) and more alcohol-induced sedation than men (ARCI sedative subscale effect size: 12; 95% CI: 2-22), but no significant gender differences were found in driving-related skills. AmEDs slightly reduced alcohol's effects on most subjective and psychomotor outcomes, but ED did not entirely offset alcohol's effects, and no interaction between the two beverages was found for either gender. After a binge-drinking episode, women reported greater drunkenness and more sedation than men. Our results support that women are more sensitive to several subjective effects of alcohol, but further studies should be conducted to better elucidate gender differences in the effects of AmEDs on driving performance.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diastolic Dysfunction is Associated with Liver Fibrosis and Insulin Resistance in Alcohol Use Disorder

  • Hernandez Rubio, Anna|||0000-0001-8612-7827
  • Ceballos, Sara|||0009-0007-4218-066X
  • García Calvo, Xavier|||0000-0001-8165-8717
  • Zuluaga Blanco, Yenny Paola|||0000-0002-0247-0351
  • López-Ayerbe, Javier
  • Faconti, Luca
  • Muga, Roberto|||0000-0001-6301-431X
  • Fuster, Daniel|||0000-0003-1262-5860
Background: Alcohol use disorder (AUD) is associated with many health consequences, including cardiomyopathy with impaired systolic function, liver disease, and metabolic disturbances. Objective: We aimed to study the main echocardiographic abnormalities in otherwise asymptomatic individuals with AUD admitted for inpatient treatment, and to assess their associations with advanced liver fibrosis and insulin resistance, including their interaction. Design: A cross-sectional study. Participants: Individuals with AUD admitted for inpatient treatment between 2019 and 2024 in a university hospital in Spain. Main measures: We ascertained demographic information, alcohol use characteristics, anthropometric measurements, blood test parameters, and echocardiography findings upon admission. We estimated liver fibrosis with the FIB-4 index and insulin resistance with the triglyceride (TG)/HDL ratio. We performed multivariate logistic regression analyses to assess the main associations between cardiac abnormalities, advanced liver fibrosis, and insulin resistance. Results: We included 145 individuals (28% women), with a median age of 53 years [Interquartile range (IQR) 48-58 years], daily alcohol consumption of 10.3 standard drink units (SDU) [IQR 6.8-16.30 SDU], and body mass index of 25.8 kg/m [IQR 22.9-30.0 kg/m]. Among them, 33% had hypertension and 14% had diabetes. The most common echocardiographic abnormality was diastolic dysfunction, which was present in 96 patients (66%), while systolic impairment was detected only in 7 cases (5%). Advanced liver fibrosis (FIB-4 > 3.25) was more prevalent in those with diastolic dysfunction (p-value = 0.010). In the multivariate logistic regression analysis, advanced liver fibrosis and TG/HDL ratio ≥ 3 were independently associated with diastolic dysfunction, with an OR of 3.53 (95% confidence interval (CI)1.20-10.41) and 4.55 (95% CI 1.57-13.22), respectively. However, no interaction between them was found (p-value for interaction = 0.92). Conclusions: Diastolic dysfunction is a common finding in apparently asymptomatic individuals with AUD admitted for inpatient treatment, and it is independently associated with advanced liver fibrosis and insulin resistance.